[Chinese guideline for diagnosis and treatment of transfusion dependent β-thalassemia (2022)]
- PMID: 36709178
- PMCID: PMC9808868
- DOI: 10.3760/cma.j.issn.0253-2727.2022.11.002
[Chinese guideline for diagnosis and treatment of transfusion dependent β-thalassemia (2022)]
Figures
Similar articles
-
[Clinical practice guidelines for beta-thalassemia].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020 Mar 10;37(3):243-251. doi: 10.3760/cma.j.issn.1003-9406.2020.03.004. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020. PMID: 32128739 Chinese.
-
Clinical Classification, Screening and Diagnosis for Thalassemia.Hematol Oncol Clin North Am. 2018 Apr;32(2):193-211. doi: 10.1016/j.hoc.2017.11.006. Hematol Oncol Clin North Am. 2018. PMID: 29458726 Review.
-
Treatment of beta-thalassemia.Curr Opin Hematol. 1997 Mar;4(2):79-87. doi: 10.1097/00062752-199704020-00002. Curr Opin Hematol. 1997. PMID: 9107523 Review.
-
[Beta-thalassemia: clinical manifestations].Bull Soc Pathol Exot. 2001 May;94(2):92-4. Bull Soc Pathol Exot. 2001. PMID: 11475035 Review. French.
-
Erythropoiesis is not equally suppressed in transfused males and females with β-thalassemia major: are there clinical implications?Haematologica. 2015 Aug;100(8):e292-4. doi: 10.3324/haematol.2014.118216. Epub 2015 Apr 24. Haematologica. 2015. PMID: 25911552 Free PMC article. No abstract available.
Cited by
-
Post-transfusion severe headache in a patient with thalassemia with superficial siderosis of the central nervous system: a case report and literature review.BMC Neurol. 2024 Jan 6;24(1):21. doi: 10.1186/s12883-024-03526-1. BMC Neurol. 2024. PMID: 38184518 Free PMC article. Review.
-
Health-related quality of life and associated factors among children with Transfusion-dependent β-thalassaemia: a cross-sectional study in Guangxi Province.Health Qual Life Outcomes. 2024 Oct 29;22(1):93. doi: 10.1186/s12955-024-02307-1. Health Qual Life Outcomes. 2024. PMID: 39468579 Free PMC article.
-
[Guidelines for iron chelation therapy in thalassemia in China (2025)].Zhongguo Dang Dai Er Ke Za Zhi. 2025 Apr 15;27(4):377-388. doi: 10.7499/j.issn.1008-8830.2411001. Zhongguo Dang Dai Er Ke Za Zhi. 2025. PMID: 40241354 Free PMC article. Chinese.
-
[Guideline for transfusion management in Chinese children with transfusion-dependent thalassemia (2025)].Zhongguo Dang Dai Er Ke Za Zhi. 2025 May 15;27(5):505-514. doi: 10.7499/j.issn.1008-8830.2410119. Zhongguo Dang Dai Er Ke Za Zhi. 2025. PMID: 40462422 Free PMC article. Chinese.
-
[Delayed physical growth and related factors in pediatric patients with transfusion-dependent thalassemia].Zhonghua Xue Ye Xue Za Zhi. 2025 Apr 14;46(4):328-335. doi: 10.3760/cma.j.cn121090-20240903-00333. Zhonghua Xue Ye Xue Za Zhi. 2025. PMID: 40425454 Free PMC article. Chinese.
References
-
- 陈 耀龙, 李 幼平, 杜 亮, et al. 医学研究中证据分级和推荐强度的演进[J] 中国循证医学杂志. 2008;8(2):127–133. doi: 10.3969/j.issn.1672-2531.2008.02.012. - DOI
-
- Cappellini MD, Farmakis D, Porter J, et al. 2021 Guidelines for the management of transfusion dependent thalassaemia (TDT) Thalassaemia international federation. 2021. - PubMed
-
- 张 俊武, 龙 桂芳. 血红蛋白与血红蛋白病[M] 南宁: 广西科学技术出版社; 2003. p. 3.
-
- Yardumian A, Telfer P, Darbyshire P. Standards for the clinical care of children and adults with thalassaemia in the UK[M] 2nd ed. London: United Kingdom Thalassaemia Society; 2008.
-
- Tanner MA, Galanello R, Dessi C, et al. A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance[J] Circulation. 2007;115(14):1876–1884. doi: 10.1161/CIRCULATIONAHA.106.648790. - DOI - PubMed